Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 210

1.

Development of a Multiantigen Panel for Improved Detection of Borrelia burgdorferi Infection in Early Lyme Disease.

Lahey LJ, Panas MW, Mao R, Delanoy M, Flanagan JJ, Binder SR, Rebman AW, Montoya JG, Soloski MJ, Steere AC, Dattwyler RJ, Arnaboldi PM, Aucott JN, Robinson WH.

J Clin Microbiol. 2015 Dec;53(12):3834-41. doi: 10.1128/JCM.02111-15. Epub 2015 Oct 7.

2.

Evaluation of Selected Borrelia burgdorferi lp54 Plasmid-Encoded Gene Products Expressed during Mammalian Infection as Antigens To Improve Serodiagnostic Testing for Early Lyme Disease.

Weiner ZP, Crew RM, Brandt KS, Ullmann AJ, Schriefer ME, Molins CR, Gilmore RD.

Clin Vaccine Immunol. 2015 Nov;22(11):1176-86. doi: 10.1128/CVI.00399-15. Epub 2015 Sep 16.

3.

Development of a multiplex assay for the detection of antibodies to Borrelia burgdorferi in horses and its validation using Bayesian and conventional statistical methods.

Wagner B, Freer H, Rollins A, Erb HN, Lu Z, Gröhn Y.

Vet Immunol Immunopathol. 2011 Dec 15;144(3-4):374-81. doi: 10.1016/j.vetimm.2011.08.005. Epub 2011 Aug 17.

PMID:
21890217
4.

Outer surface protein C peptide derived from Borrelia burgdorferi sensu stricto as a target for serodiagnosis of early lyme disease.

Arnaboldi PM, Seedarnee R, Sambir M, Callister SM, Imparato JA, Dattwyler RJ.

Clin Vaccine Immunol. 2013 Apr;20(4):474-81. doi: 10.1128/CVI.00608-12. Epub 2013 Jan 30.

5.

Simple objective detection of human lyme disease infection using immuno-PCR and a single recombinant hybrid antigen.

Halpern MD, Molins CR, Schriefer M, Jewett MW.

Clin Vaccine Immunol. 2014 Aug;21(8):1094-105. doi: 10.1128/CVI.00245-14. Epub 2014 Jun 4.

6.

Five-Antigen Fluorescent Bead-Based Assay for Diagnosis of Lyme Disease.

Embers ME, Hasenkampf NR, Barnes MB, Didier ES, Philipp MT, Tardo AC.

Clin Vaccine Immunol. 2016 Apr 4;23(4):294-303. doi: 10.1128/CVI.00685-15. Print 2016 Apr.

7.

Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay.

Branda JA, Linskey K, Kim YA, Steere AC, Ferraro MJ.

Clin Infect Dis. 2011 Sep;53(6):541-7. doi: 10.1093/cid/cir464.

PMID:
21865190
8.

Prospective study of serologic tests for lyme disease.

Steere AC, McHugh G, Damle N, Sikand VK.

Clin Infect Dis. 2008 Jul 15;47(2):188-95. doi: 10.1086/589242.

9.

Multiplex immunoassay for Lyme disease using VlsE1-IgG and pepC10-IgM antibodies: improving test performance through bioinformatics.

Porwancher RB, Hagerty CG, Fan J, Landsberg L, Johnson BJ, Kopnitsky M, Steere AC, Kulas K, Wong SJ.

Clin Vaccine Immunol. 2011 May;18(5):851-9. doi: 10.1128/CVI.00409-10. Epub 2011 Mar 2.

10.

Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates.

Bacon RM, Biggerstaff BJ, Schriefer ME, Gilmore RD Jr, Philipp MT, Steere AC, Wormser GP, Marques AR, Johnson BJ.

J Infect Dis. 2003 Apr 15;187(8):1187-99. Epub 2003 Apr 2.

PMID:
12695997
11.

Recombinant OspC from Borrelia burgdorferi sensu stricto, B. afzelii and B. garinii in the serodiagnosis of Lyme borreliosis.

Panelius J, Lahdenne P, Heikkilä T, Peltomaa M, Oksi J, Seppälä I.

J Med Microbiol. 2002 Sep;51(9):731-9.

PMID:
12358063
12.

Evaluation of the recombinant VlsE-based liaison chemiluminescence immunoassay for detection of Borrelia burgdorferi and diagnosis of Lyme disease.

Ledue TB, Collins MF, Young J, Schriefer ME.

Clin Vaccine Immunol. 2008 Dec;15(12):1796-804. doi: 10.1128/CVI.00195-08. Epub 2008 Oct 22.

13.

Predictive value of Borrelia burgdorferi IgG antibody levels in patients referred to a tertiary Lyme centre.

Zwerink M, Zomer TP, van Kooten B, Blaauw G, van Bemmel T, van Hees BC, Vermeeren YM, Landman GW.

Ticks Tick Borne Dis. 2018 Mar;9(3):594-597. doi: 10.1016/j.ttbdis.2017.12.014. Epub 2017 Dec 24.

PMID:
29422448
14.

Application of multiplexing technology to the analysis of the intrathecally released immunoglobulins against B. burgdorferi antigens in neuroborreliosis.

Zajkowska J, Lelental N, Kulakowska A, Mroczko B, Pancewicz S, Bucki R, Kornhuber J, Lewczuk P.

Immunol Lett. 2015 Nov;168(1):58-63. doi: 10.1016/j.imlet.2015.07.001. Epub 2015 Jul 22.

PMID:
26210581
16.

Decorin binding proteins A and B in the serodiagnosis of Lyme disease in North America.

Arnaboldi PM, Sambir M, Dattwyler RJ.

Clin Vaccine Immunol. 2014 Oct;21(10):1426-36. doi: 10.1128/CVI.00383-14. Epub 2014 Aug 13.

17.

C6 Peptide-Based Multiplex Phosphorescence Analysis (PHOSPHAN) for Serologic Confirmation of Lyme Borreliosis.

Pomelova VG, Korenberg EI, Kuznetsova TI, Bychenkova TA, Bekman NI, Osin NS.

PLoS One. 2015 Jul 6;10(7):e0130048. doi: 10.1371/journal.pone.0130048. eCollection 2015.

18.

Evaluation of two commercially available rapid diagnostic tests for Lyme borreliosis.

Smit PW, Kurkela S, Kuusi M, Vapalahti O.

Eur J Clin Microbiol Infect Dis. 2015 Jan;34(1):109-113. doi: 10.1007/s10096-014-2217-5. Epub 2014 Jul 31.

PMID:
25073771
19.

Significantly improved accuracy of diagnosis of early Lyme disease by peptide enzyme-linked immunosorbent assay based on the borreliacidal antibody epitope of Borrelia burgdorferi OspC.

Jobe DA, Lovrich SD, Asp KE, Mathiason MA, Albrecht SE, Schell RF, Callister SM.

Clin Vaccine Immunol. 2008 Jun;15(6):981-5. doi: 10.1128/CVI.00079-08. Epub 2008 Apr 16.

20.

Borrelia burgdorferi-specific IgA in Lyme Disease.

D'Arco C, Dattwyler RJ, Arnaboldi PM.

EBioMedicine. 2017 May;19:91-97. doi: 10.1016/j.ebiom.2017.04.025. Epub 2017 Apr 21.

Supplemental Content

Support Center